Clario Respiratory Solutions outlines a centralized, technology-driven approach to improving respiratory data quality in clinical trials. The document explains how variability, protocol complexity, and inconsistent site performance can compromise pulmonary endpoints and how Clario mitigates these risks through centralized spirometry and pulmonary function testing (PFTs). Services include AI-assisted overread, hybrid and virtual home spirometry, cough and lung sound analysis, DLCO, LCI, FeNO, FOT, and integrated ePROs. Emphasis is placed on ATS/ERS guideline adherence, near–real-time quality feedback, and global training support. The brochure highlights Clario’s extensive experience supporting over 1,700 respiratory trials and more than 90% of respiratory drug approvals since 2012, position

Join for free to read